Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2009 Sep;65(9):955-6; author reply 957.
doi: 10.1007/s00228-009-0661-4. Epub 2009 May 5.

Long-term retention rate of pramipexole in the treatment of Parkinson's disease

Tapani Keränen, Mervi Tuhkasaari, Hanna Kuusisto
Comment

Long-term retention rate of pramipexole in the treatment of Parkinson's disease

Tapani Keränen et al. Eur J Clin Pharmacol. 2009 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/s00228-008-0518-2', 'is_inner': False, 'url': 'https://doi.org/10.1007/s00228-008-0518-2'}, {'type': 'PubMed', 'value': '18626634', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/18626634/'}]}
    2. Arbouw ME, Movig KL, Guchelaar HJ, Poels PJ, van Vugt JP, Neef C, Egberts TC (2008) Discontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials. Eur J Clin Pharmacol 64:1021–1026 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/mds.20041', 'is_inner': False, 'url': 'https://doi.org/10.1002/mds.20041'}, {'type': 'PubMed', 'value': '15133814', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15133814/'}]}
    2. Leopold NA, Polansky M, Hurka MR (2004) Drug adherence in Parkinson’s disease. Mov Disord 19:513–517 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.2217/14622416.8.2.159', 'is_inner': False, 'url': 'https://doi.org/10.2217/14622416.8.2.159'}, {'type': 'PubMed', 'value': '17286539', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17286539/'}]}
    2. Arbouw ME, van Vugt JP, Egberts TC, Guchelaar HJ (2007) Pharmacogenetics of antiparkinsonian drug treatment: a systematic review. Pharmacogenomics 8:159–176 - PubMed

MeSH terms